Monday, August 11, 2014

Hemispherx Biopharma Announces Financial Results For The Six Months Ended June 30, 2014

Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations



via Business - United States - Latest News http://ift.tt/XX3ZAB
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)